Leveraging cancer metabolism to translate into effective therapeutics
Seminars in Cancer Biology · 2026-01 · 118 · 44-61
DOI: 10.1016/j.semcancer.2025.12.003 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Cancer Biology, 2026-01. Verfasst von Jie Xu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 401120, China. Hauptthemen laut MEDLINE: Neoplasms, Energy Metabolism. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 441 Literaturangaben. Gefördert von: National Institutes of Health, Stephenson Cancer Center, Chongqing Municipal Education Commission.
Abstract (Originalsprache)
Abnormal metabolism is a typical characteristic of malignant tumors, broadly influencing the outcome of cancer therapy. Research on tumor metabolism has increased exponentially in last decades. There is an urgent need to provide a blueprint or framework to accelerate the translation of cancer metabolism research into effective therapeutics. In this review, we summarize the impact of metabolism on cancer progression and emerging metabolic therapies, and systematically outline potential clinical applications in cancer prevention, early screening, diagnosis, treatment, and new challenges. Furthermore, we aim to provide researchers and clinicians with a clearer perspective on the immediate translation of clinical applications stemming from cancer metabolism research. It will revolutionize cancer management and significantly enhance patient survival.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 401120, China.
- Department of Microbiology and Immunology, The Indiana University School of Medicine, Indianapolis, IN 46202, USA.
- Translational Clinical Immunology Medicine Key Laboratory of Sichuan Province, Sichuan Provincial People's Hospital, Chengdu 610072, China.
- Institute of Cardiovascular Diseases and Department of Cardiology, Ultrasound in Cardiac Electrophysiology and Biomechanics Key Laboratory of Sichuan Province, Sichuan Provincial People's Hospital, Chengdu 610072, China.
- Department of Obstetrics and Gynecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 401120, China. Electronic address: yiping@cqmu.edu.cn.
- Department of Oncology Science, OU Health Stephenson Cancer Center at University of Oklahoma Health Sciences Center, Oklahoma, OK 73104, USA. Electronic address: Chunming-Cheng@ouhsc.edu.
Förderung
- National Institutes of Health
- Stephenson Cancer Center
- Chongqing Municipal Education Commission
Zitieren
APA
Xu, J., Guo, L., Wang, Y., Li, X., Yi, P., & Cheng, C. (2026). Leveraging cancer metabolism to translate into effective therapeutics. Seminars in Cancer Biology, 118, 44-61. https://doi.org/10.1016/j.semcancer.2025.12.003
Vancouver
Xu J, Guo L, Wang Y, Li X, Yi P, Cheng C. Leveraging cancer metabolism to translate into effective therapeutics. Seminars in Cancer Biology. 2026;118:44-61. doi:10.1016/j.semcancer.2025.12.003
BibTeX
@article{Xu2026,
author = {Xu, Jie and Guo, Linlin and Wang, Yi and Li, Xiaoping and Yi, Ping and Cheng, Chunming},
title = {Leveraging cancer metabolism to translate into effective therapeutics},
journal = {Seminars in Cancer Biology},
year = {2026},
volume = {118},
pages = {44--61},
doi = {10.1016/j.semcancer.2025.12.003}
}
EUVIMED